Prevalence of Toxoplasma gondii among immunocompromised patients (heamodialysis and cancer) in the province of Thi-Qar-Iraq

Authors

  • Noor Kadhim Matar AL-Rekaby Biology Department / College Science / Thi Qar university
  • Bassad A.AL-Aboody Biology Department / College Science / Thi Qar university

DOI:

https://doi.org/10.32792/utq/utjsci/v6i3.41

Keywords:

Toxoplasmosis, Hemodialysis, immunocompromised patients, Lipid profile, ELISA Test

Abstract

The current study was conducted in Thi-Qar province to investigate of Toxoplasma gondii prevalence
among renal dialysis and cancer patients by using anti-Toxoplasmosis IgG and IgM by ELISA also the study
determined of some factors that may affected the prevalence of infection, such as age, sex, marital status,
place of residence and a number of chemical dosing that exposed to it cancer patient or the number of times
the dialysis for renal dialysis patients.
The results of the current study showed that the prevalence of toxoplasmosis in Thi-Qar province in
both renal dialysis and cancer patients and control group were 28% and 36% and 24% respectively. recorded
results of Enzyme Linked Immunosorbent Assay ELISA test results for a positive antibody IgG in both renal
dialysis and cancer patients and control group 25% , 30% , 22% respectively. As for the IgM antibody study
did not record any positive result in both categories of the study (dialysis and cancer) only control group was
2%. The result of IgG & IgM together in renal dialysis and cancer and control group 3%, 6%, 0%
respectively.
The study found that the increase in the number of times the dialysis increased incidence of infection
prevalence it was 25.53% for patients who conducted the dialysis treatment more than six times and 16.66%
for patients who have less than six times.For factor chemical dosing show high infection rates in patients who
have been exposed to more than one dose of a chemical 37.63%.

Downloads

Published

2017-12-19

Issue

Section

Articles

How to Cite

Prevalence of Toxoplasma gondii among immunocompromised patients (heamodialysis and cancer) in the province of Thi-Qar-Iraq. (2017). University of Thi-Qar Journal of Science, 6(3), 101-106. https://doi.org/10.32792/utq/utjsci/v6i3.41